+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Non-iodinated X-ray Contrast Agents Market - Global Forecast 2025-2030- Product Image
Non-iodinated X-ray Contrast Agents Market - Global Forecast 2025-2030- Product Image
Sale

Non-iodinated X-ray Contrast Agents Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6145663
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Non-iodinated contrast agents are reshaping the diagnostic imaging landscape, offering viable alternatives to traditional iodinated media and catering to critical needs for enhanced safety, technological compatibility, and evolving regulatory standards.

Market Snapshot: Non-iodinated Contrast Agent Market

The global non-iodinated contrast agent market is experiencing transformative growth, propelled by advancements in diagnostic technologies and increasing clinical preference for safer imaging solutions. Rising awareness around the risks associated with iodinated media has fueled the adoption of formulations such as barium sulfate, carbon dioxide, and air-based agents. Sophisticated radiology systems and surging demand for minimally invasive diagnostics further accentuate the importance of these alternatives. Market participants are adapting to a dynamic environment shaped by clinical trends, regulatory updates, and changing reimbursement frameworks.

Scope & Segmentation Analysis

This comprehensive report analyzes the full spectrum of the non-iodinated contrast agent ecosystem, spanning product types, clinical applications, administration methods, end users, and key regions. Innovations and regulatory shifts are explored to provide high-impact insight for strategic decisions.

  • Product Types: Highlights air-based media for rapid transit imaging, barium sulfate solutions for stable gastrointestinal diagnostics, and carbon dioxide agents for procedures requiring minimal systemic exposure.
  • Applications: Covers angiography—including cerebral, coronary, and peripheral artery imaging—and upper and lower gastrointestinal studies, each with distinct imaging and workflow demands.
  • Routes of Administration: Reviews intravenous, oral, and rectal approaches, reflecting the diversity of diagnostic pathways and clinical settings.
  • End Users: Analyzes adoption across imaging centers, outpatient clinics, diagnostic centers, and private as well as public hospitals, each with unique infrastructure and volume requirements.
  • Formulation Options: Examines powder-based and suspension formulations for their respective benefits in storage and immediate use.
  • Key Regions: Delivers coverage of the Americas (including major U.S. states), Europe, Middle East, Africa, and Asia-Pacific markets, providing an in-depth view of regional opportunities and challenges.
  • Leading Companies: Profiles established and emerging firms, including Guerbet SA, Bracco Imaging S.p.A., Mallinckrodt plc, and several specialty pharmaceutical leaders in the Asia-Pacific region.

Key Takeaways

  • Advancements in nanotechnology and biomolecular engineering are accelerating the introduction of non-iodinated contrast agents with tailored imaging profiles and prolonged circulation times.
  • Clinical strategies are increasingly centered on personalized medicine, with non-iodinated agents aligning with efforts to reduce toxicity and hypersensitivity in vulnerable populations.
  • Strong regulatory engagement and evolving international guidelines are paving the way for wider market adoption, emphasizing robust preclinical validation and intensive post-market monitoring.
  • Hospitals and imaging centers are adapting workflows to accommodate new agent types across a variety of diagnostic scenarios, from cerebral angiography to gastrointestinal imaging.
  • Integration of artificial intelligence and advanced analytics in radiology platforms is raising the bar for contrast agent consistency and performance, driving further innovation in both formulation and supply chain management.
  • Collaborative partnerships, including alliances between major producers and research institutions, are streamlining product development and market penetration while reinforcing intellectual property strategies.

Tariff Impact

The introduction of new U.S. tariffs in 2025 has significantly impacted the non-iodinated contrast agent supply chain, affecting production costs and procurement strategies for key raw materials such as barium compounds and carrier gases. These tariffs have prompted manufacturers to diversify suppliers and explore regional partnerships, as well as encouraged joint R&D efforts to develop lower-cost synthetic alternatives. Healthcare providers and distributors are adopting new purchasing models to mitigate cost pressures while maintaining access to critical diagnostic agents.

Non-iodinated Contrast Agent Market: Methodology & Data Sources

This report is built on an integrated approach combining extensive secondary research from peer-reviewed journals, regulatory filings, and industry publications with primary insights from structured interviews across the value chain. Quantitative data is triangulated with expert opinions and qualitative assessments, ensuring findings are robust, timely, and market-relevant.

Why This Report Matters

  • Enables data-driven decision-making by illuminating segmentation, regional trends, and supply chain risks across the non-iodinated contrast agent market.
  • Empowers strategic planning by assessing product innovation, technology integration, and the impact of emergent trade policies on market accessibility.
  • Supports commercial and clinical stakeholders in aligning product selection with evolving regulatory, sustainability, and patient safety criteria.

Conclusion

Non-iodinated contrast agents are redefining diagnostic imaging standard practices. This study equips decision-makers with actionable insights to support innovation, resilience, and sustained value in a rapidly evolving market.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of biodegradable nanoparticle-based non-iodinated X-ray contrast agents for improved safety in pediatric imaging
5.2. Expansion of multifunctional metal-organic framework non-iodinated contrast agents enabling simultaneous CT imaging and targeted drug delivery
5.3. Advances in gold nanoparticle-based non-iodinated X-ray contrast agents offering enhanced tumor delineation and reduced toxicity
5.4. Accelerated regulatory approvals for novel non-iodinated contrast formulations emphasizing gadolinium-free compounds
5.5. Integration of AI-driven imaging protocols with non-iodinated X-ray contrast agents for personalized diagnostic accuracy
5.6. Emergence of cost-effective polysaccharide-coated bismuth nanoparticles as sustainable non-iodinated CT contrast agents
5.7. Increased clinical research on fluorine-based non-iodinated contrast agents for dual-energy spectral CT applications
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Non-iodinated X-ray Contrast Agents Market, by Product
8.1. Introduction
8.2. Air
8.3. Barium Sulfate
8.4. Carbon Dioxide
9. Non-iodinated X-ray Contrast Agents Market, by Application
9.1. Introduction
9.2. Angiography
9.2.1. Cerebral Artery
9.2.2. Coronary Artery
9.2.3. Peripheral Artery
9.3. Gastrointestinal Imaging
9.3.1. Lower Gastrointestinal
9.3.2. Upper Gastrointestinal
10. Non-iodinated X-ray Contrast Agents Market, by Route Of Administration
10.1. Introduction
10.2. Intravenous
10.3. Oral
10.4. Rectal
11. Non-iodinated X-ray Contrast Agents Market, by End User
11.1. Introduction
11.2. Ambulatory Care
11.2.1. Imaging Centers
11.2.2. Outpatient Clinics
11.3. Diagnostic Centers
11.4. Hospitals
11.4.1. Private Hospitals
11.4.2. Public Hospitals
12. Non-iodinated X-ray Contrast Agents Market, by Formulation
12.1. Introduction
12.2. Powder
12.3. Suspension
13. Americas Non-iodinated X-ray Contrast Agents Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Non-iodinated X-ray Contrast Agents Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Non-iodinated X-ray Contrast Agents Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Guerbet SA
16.3.2. Bracco Imaging S.p.A.
16.3.3. Mallinckrodt plc
16.3.4. E-Z-EM, Inc.
16.3.5. Sanochemia Pharmazeutika AG
16.3.6. China National Pharmaceutical Group Co., Ltd.
16.3.7. Jiangsu Hengrui Medicine Co., Ltd.
16.3.8. Sichuan Kelun Pharmaceutical Co., Ltd.
16.3.9. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
16.3.10. Merck KGaA
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. NON-IODINATED X-RAY CONTRAST AGENTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NON-IODINATED X-RAY CONTRAST AGENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NON-IODINATED X-RAY CONTRAST AGENTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. NON-IODINATED X-RAY CONTRAST AGENTS MARKET: RESEARCHAI
FIGURE 26. NON-IODINATED X-RAY CONTRAST AGENTS MARKET: RESEARCHSTATISTICS
FIGURE 27. NON-IODINATED X-RAY CONTRAST AGENTS MARKET: RESEARCHCONTACTS
FIGURE 28. NON-IODINATED X-RAY CONTRAST AGENTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NON-IODINATED X-RAY CONTRAST AGENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY BARIUM SULFATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY BARIUM SULFATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY CARBON DIOXIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY CARBON DIOXIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY CEREBRAL ARTERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY CEREBRAL ARTERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY CORONARY ARTERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY CORONARY ARTERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PERIPHERAL ARTERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PERIPHERAL ARTERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY LOWER GASTROINTESTINAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY LOWER GASTROINTESTINAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY UPPER GASTROINTESTINAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY UPPER GASTROINTESTINAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY RECTAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY RECTAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY SUSPENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 111. CANADA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 112. CANADA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 113. CANADA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. CANADA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. CANADA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 116. CANADA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 117. CANADA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2018-2024 (USD MILLION)
TABLE 118. CANADA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2025-2030 (USD MILLION)
TABLE 119. CANADA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. CANADA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. CANADA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 124. CANADA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 125. CANADA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 126. CANADA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 127. CANADA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 128. CANADA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 129. MEXICO NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 130. MEXICO NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 131. MEXICO NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. MEXICO NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. MEXICO NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 134. MEXICO NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 135. MEXICO NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2018-2024 (USD MILLION)
TABLE 136. MEXICO NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2025-2030 (USD MILLION)
TABLE 137. MEXICO NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 138. MEXICO NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 139. MEXICO NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. MEXICO NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. MEXICO NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 142. MEXICO NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 143. MEXICO NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 144. MEXICO NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 145. MEXICO NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 146. MEXICO NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 221. GERMANY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 222. GERMANY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 223. GERMANY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. GERMANY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. GERMANY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 226. GERMANY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 227. GERMANY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2018-2024 (USD MILLION)
TABLE 228. GERMANY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2025-2030 (USD MILLION)
TABLE 229. GERMANY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 230. GERMANY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 231. GERMANY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. GERMANY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. GERMANY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 234. GERMANY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 235. GERMANY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 236. GERMANY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 237. GERMANY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 238. GERMANY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 239. FRANCE NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 240. FRANCE NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 241. FRANCE NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. FRANCE NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. FRANCE NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 244. FRANCE NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 245. FRANCE NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2018-2024 (USD MILLION)
TABLE 246. FRANCE NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2025-2030 (USD MILLION)
TABLE 247. FRANCE NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. FRANCE NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. FRANCE NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. FRANCE NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. FRANCE NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 252. FRANCE NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 253. FRANCE NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 254. FRANCE NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 255. FRANCE NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 256. FRANCE NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 275. ITALY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 276. ITALY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 277. ITALY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. ITALY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. ITALY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 280. ITALY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ANGIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 281. ITALY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2018-2024 (USD MILLION)
TABLE 282. ITALY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY GASTROINTESTINAL IMAGING, 2025-2030 (USD MILLION)
TABLE 283. ITALY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 284. ITALY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 285. ITALY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. ITALY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. ITALY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 288. ITALY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 289. ITALY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 290. ITALY NON-IODINATED X-RAY CONTRAST AGENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 291. ITALY NON-IODINATED X-RAY CONTRAST AGENTS MAR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Non-iodinated X-ray Contrast Agents market report include:
  • Guerbet SA
  • Bracco Imaging S.p.A.
  • Mallinckrodt plc
  • E-Z-EM, Inc.
  • Sanochemia Pharmazeutika AG
  • China National Pharmaceutical Group Co., Ltd.
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
  • Merck KGaA

Related Topics

Related Reports

Iodinated X-Ray Contrast Media Market - Global Forecast 2025-2030 - Product Image

Iodinated X-Ray Contrast Media Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
X-Ray Contrast Media Market - Global Forecast to 2030 - Product Image

X-Ray Contrast Media Market - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
X-ray Digital Subtraction Angiography Machine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

X-ray Digital Subtraction Angiography Machine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
X-Ray Detector Market Report by Type, Portability, Application, and Region 2025-2033 - Product Image

X-Ray Detector Market Report by Type, Portability, Application, and Region 2025-2033

  • Report
  • 135 Pages
  • Global
From
Diagnostic Imaging Market by Modality (MRI (Very High (7T+), High (3T+), Low (<3T)), Ultrasound (3D/4D, Doppler, Contrast), CT, X-Ray (Digital, Portable), Mammography, SPECT, PET)), Application (OB/Gyn, CVD, Onco, Neuro) & End User-Global Forecast to 2030 - Product Image

Diagnostic Imaging Market by Modality (MRI (Very High (7T+), High (3T+), Low (<3T)), Ultrasound (3D/4D, Doppler, Contrast), CT, X-Ray (Digital, Portable), Mammography, SPECT, PET)), Application (OB/Gyn, CVD, Onco, Neuro) & End User-Global Forecast to 2030

  • Report
  • 394 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.